ThyroidVol. 8, No. 5 Clinical Presentation of Thyroid Associated OrbitopathyPAT KENDALL-TAYLOR and PETROS PERROSPAT KENDALL-TAYLORSearch for more papers by this author and PETROS PERROSSearch for more papers by this authorPublished Online:3 Feb 2009https://doi.org/10.1089/thy.1998.8.427AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Clinical Presentation of Thyroid Associated Orbitopathy." , 8(5), pp. 427–428FiguresReferencesRelatedDetailsCited ByMaladie de BasedowExtrathyroidal Manifestations of Thyroid DiseaseNeuroimaging Clinics of North America, Vol. 31, No. 3Recent advances in thyroid eye disease: An overview15 July 2021 | IP International Journal of Ocular Oncology and Oculoplasty, Vol. 7, No. 2Evaluating the Thyroid Eye Disease Patient23 March 2021 | International Ophthalmology Clinics, Vol. 61, No. 2The Role of Vitamin D Receptor Gene Polymorphisms in Thyroid-Associated Orbitopathy19 August 2019 | Ocular Immunology and Inflammation, Vol. 46Association of Risk of Obstructive Sleep Apnea With Thyroid Eye Disease: Compressive Optic NeuropathyOphthalmic Plastic & Reconstructive Surgery, Vol. 35, No. 3Thyroid Eye Disease28 April 2019Optical Coherence Tomography Thickness Measurements of the Extraocular Rectus Muscle Tendons in Graves' OphthalmopathyJournal of Pediatric Ophthalmology & Strabismus, Vol. 55, No. 6Response to tocilizumab treatment in Graves’ ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomographyArchivos de la Sociedad Española de Oftalmología (English Edition), Vol. 93, No. 8Evaluación del grosor de los músculos extraoculares y la quemosis tras tocilizumab en oftalmopatía de Graves mediante tomografía de coherencia ópticaArchivos de la Sociedad Española de Oftalmología, Vol. 93, No. 8Grading Severity and Activity in Thyroid Eye DiseaseOphthalmic Plastic & Reconstructive Surgery, Vol. 34, No. 4SMedical and Surgical Options in Thyroid Eye Disease27 June 2018Raising awareness of Graves' orbitopathy with early warning cards4 September 2017 | Clinical Endocrinology, Vol. 87, No. 6An Animal Model of Graves’ Orbitopathy2 December 2015Recurrent Thyroid Eye DiseaseOphthalmic Plastic & Reconstructive Surgery, Vol. 31, No. 6Natural History of Thyroid Eye Disease24 October 2014Difficult-to-Treat HyperthyroidismAssessment and Management Plan for Graves’ OrbitopathyEvaluating Graves’ OrbitopathyBest Practice & Research Clinical Endocrinology & Metabolism, Vol. 26, No. 3Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy9 December 2011 | Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 250, No. 3Evaluation of Hyperthyroidism and Hyperthyroid Goiter15 June 2012Maladie de BasedowThyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma26 August 2005 | Eye, Vol. 20, No. 6Predictors of Disease Severity in Thyroid-Related Orbitopathy9 April 2013Evaluation of Extraocular Muscles in the Edematous Phase of Graves Ophthalmopathy on Contrast-Enhanced Fat-Suppressed Magnetic Resonance ImagingJournal of Computer Assisted Tomography, Vol. 28, No. 1La thyroïdectomie aggrave-t-elle l'ophtalmopathie basedowienne ?Annales de Chirurgie, Vol. 128, No. 2Epidemiology and Prevention of Graves' Ophthalmopathy9 July 2004 | Thyroid, Vol. 12, No. 10Serum Levels of Tumor Necrosis Factor-α, Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Cell Adhesion Molecule-1, and Soluble Interleukin-1 Receptor Antagonist in Patients with Thyroid Eye Disease Undergoing Treatment with Somatostatin Analogues9 July 2004 | Thyroid, Vol. 11, No. 12Thyroid-associated orbitopathy developed during hormone replacement therapy20 December 2001 | Acta Ophthalmologica Scandinavica, Vol. 79, No. 4Clinical Presentation and Natural History of Graves’ OphthalmopathyIncreased Frequency of Euthyroid Ophthalmopathy in Patients with Graves' Disease Associated with Myasthenia Gravis30 January 2009 | Thyroid, Vol. 10, No. 9Management of Graves’ Ophthalmopathy: Reality and Perspectives*7 November 2016 | Endocrine Reviews, Vol. 21, No. 2Thyroid-Associated Ophthalmopathy: Clinical Features, Pathogenesis, and Management29 September 2008 | Critical Reviews in Clinical Laboratory Sciences, Vol. 37, No. 6Evaluation of Hyperthyroidism and Hyperthyroid Goiter Volume 8Issue 5May 1998 To cite this article:PAT KENDALL-TAYLOR and PETROS PERROS.Clinical Presentation of Thyroid Associated Orbitopathy.Thyroid.May 1998.427-428.http://doi.org/10.1089/thy.1998.8.427Published in Volume: 8 Issue 5: February 3, 2009PDF download